Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429273 · ClinicalTrials.gov registry record · Phase 4
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 212
- Enrollment target
NCT00429273 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 212 participants.
The verdict
NCT00429273, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 212 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a single drug versus a combination of drugs in treating attention deficit hyperactivity disorder in children.
Interventions
- DRUG Guanfacine
- DRUG Methylphenidate (MPH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429273
The ClinicalTrials.gov registry entry for NCT00429273 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Guanfacine is the first listed.
NCT00429273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429273 about?
NCT00429273 is a clinical study titled "Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder". This study will evaluate the effectiveness of a single drug versus a combination of drugs in treating attention deficit hyperactivity disorder in children.
What is the current status of trial NCT00429273?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 212 participants. The study started on 2007-01. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00429273?
The interventions under investigation include: Guanfacine (DRUG), Methylphenidate (MPH) (DRUG).
Who is sponsoring clinical trial NCT00429273?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.